Over the last two decades, Beatriz Thomé, MD, MPH, PhD, has worked as a pediatrician, research manager, university lecturer, and monitoring & evaluation specialist in countries as geographically disperse as Mozambique, Switzerland, and her native Brazil. When asked what’s the thread that ties together her wide-ranging career in public health, global health, and medicine, Thomé responds with a simple question: How can I contribute?

Founded in 1987 by Dr. Steve Gloyd, the University of Washington Department of Global Health Master of Public Health (MPH) program is one of the premier global health programs in the world, offering a unique combination of scholarship and activism.

For nearly seventeen months, the COVID-19 Literature Situation Report provided up-to-date information to the public health community about scientific evidence relevant to the COVID-19 pandemic. After more than 330 daily summaries, the project – a partnership between the Washington Department of Health (WA DOH) and University of Washington Department of Global Health (DGH) – ended on June 15, 2021.

Global health researchers at the University of Washington have received a $122 million grant from the Bill & Melinda Gates Foundation to test the effectiveness of the candidate drug islatravir, a once-a-month oral pill to prevent HIV.

The five-year grant will support the implementation of a Phase 3, randomized trial of islatravir, among women, in seven countries in sub-Saharan Africa. Islatravir is a nucleoside reverse transcriptase translocation inhibitor in development by Merck for the treatment and prevention of HIV-1 infection.

On Friday, June 11, the Department of Global Health (DGH) honored the Class of 2021 with a virtual graduation celebration. During the annual event, the 14th since the department was founded in 2007, speakers acknowledged the unique challenges and opportunities of the previous year, particularly for students entering the field of global health. 

WASHINGTON — As it drafts its next decadal strategic plan, the U.S. Global Change Research Program (USGCRP) should shift its focus to providing insights that help society prepare for and avoid the worst potential consequences of climate change, while protecting the most vulnerable, says a new report from the National Academies of Sciences, Engineering, and Medicine.

By Matthew L. Tobey, Jason Beste, Phuoc Le, Sriram Shamasunder, and Jeff Robison

Originally published on Health Affairs

Severe COVID-19 is associated with critical illness and immune dysregulation, both of which have been previously associated with increased risk of nosocomial infection. The care of COVID-19 patients has required dramatic changes to usual hospital practices and heightened concern for infection control practices. This is a brief summary of published evidence related to the effect of the COVID-19 pandemic on non-COVID infections.

by Lisa Stiffler  / March 19, 2021

With COVID-19 vaccines still in limited supply and case counts threatening to resurge, there is a debate over the benefits of giving more people their first shot and waiting a longer time to administer the second dose, or whether to stay the course and prioritize getting both doses of the Pfizer and Moderna vaccine into arms as quickly as possible.

Study took place in KwaZulu Natal, South Africa, among 162 people living with HIV; findings presented at Virtual CROI 2021.

Home delivery of HIV medicines in South Africa significantly increased viral suppression compared to those who received clinical care, according to a study by researchers at the University of Washington School of Medicine.